Wan Lin Yeo

602 total citations
12 papers, 435 citations indexed

About

Wan Lin Yeo is a scholar working on Molecular Biology, Pharmacology and Pharmaceutical Science. According to data from OpenAlex, Wan Lin Yeo has authored 12 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 4 papers in Pharmacology and 4 papers in Pharmaceutical Science. Recurrent topics in Wan Lin Yeo's work include Fluorine in Organic Chemistry (4 papers), Microbial Natural Products and Biosynthesis (4 papers) and Enzyme Catalysis and Immobilization (3 papers). Wan Lin Yeo is often cited by papers focused on Fluorine in Organic Chemistry (4 papers), Microbial Natural Products and Biosynthesis (4 papers) and Enzyme Catalysis and Immobilization (3 papers). Wan Lin Yeo collaborates with scholars based in Singapore, United States and Taiwan. Wan Lin Yeo's co-authors include Yee Hwee Lim, Huimin Zhao, Ee Lui Ang, Fong Tian Wong, Mingzi M. Zhang, Elena Heng, Shangwen Luo, Ryan E. Cobb, Behnam Enghiad and Yajie Wang and has published in prestigious journals such as Angewandte Chemie International Edition, PLoS ONE and Chemical Communications.

In The Last Decade

Wan Lin Yeo

11 papers receiving 423 citations

Peers

Wan Lin Yeo
Oliver Puk Germany
Sunghoon Hwang South Korea
Rory F. Little New Zealand
Hengqian Ren United States
Katharine R. Watts United States
D.P. Cogan United States
Oliver Puk Germany
Wan Lin Yeo
Citations per year, relative to Wan Lin Yeo Wan Lin Yeo (= 1×) peers Oliver Puk

Countries citing papers authored by Wan Lin Yeo

Since Specialization
Citations

This map shows the geographic impact of Wan Lin Yeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wan Lin Yeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wan Lin Yeo more than expected).

Fields of papers citing papers by Wan Lin Yeo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wan Lin Yeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wan Lin Yeo. The network helps show where Wan Lin Yeo may publish in the future.

Co-authorship network of co-authors of Wan Lin Yeo

This figure shows the co-authorship network connecting the top 25 collaborators of Wan Lin Yeo. A scholar is included among the top collaborators of Wan Lin Yeo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wan Lin Yeo. Wan Lin Yeo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Verma, Ravi Kumar, Wan Lin Yeo, Ee Lui Ang, et al.. (2025). Unveiling the molecular basis of selective fluorination of SAM-dependent fluorinases. Chemical Science. 16(23). 10610–10619.
3.
Yeo, Wan Lin, Jin Xu, Hao Fan, et al.. (2023). Directed Evolution and Computational Modeling of Galactose Oxidase toward Bulky Benzylic and Alkyl Secondary Alcohols. ACS Catalysis. 13(24). 16088–16096. 7 indexed citations
4.
Yeo, Wan Lin, Elena Heng, Tsai‐Ling Lauderdale, et al.. (2020). Biosynthetic engineering of the antifungal, anti-MRSA auroramycin. Microbial Cell Factories. 19(1). 3–3. 11 indexed citations
5.
Kong, Kiat Whye, Shawn Hoon, Wan Lin Yeo, et al.. (2019). Chemogenomic profiling in yeast reveals antifungal mode-of-action of polyene macrolactam auroramycin. PLoS ONE. 14(6). e0218189–e0218189. 10 indexed citations
6.
Yeo, Wan Lin, Elena Heng, Yee Hwee Lim, et al.. (2019). Characterization of Cas proteins for CRISPR‐Cas editing in streptomycetes. Biotechnology and Bioengineering. 116(9). 2330–2338. 30 indexed citations
7.
Lim, Yee Hwee, Fong Tian Wong, Wan Lin Yeo, et al.. (2018). Auroramycin: A Potent Antibiotic from Streptomyces roseosporus by CRISPR‐Cas9 Activation. ChemBioChem. 19(16). 1716–1719. 42 indexed citations
8.
Zhang, Mingzi M., Fong Tian Wong, Yajie Wang, et al.. (2017). CRISPR–Cas9 strategy for activation of silent Streptomyces biosynthetic gene clusters. Nature Chemical Biology. 13(6). 607–609. 224 indexed citations
9.
Yeo, Wan Lin, Derek J. Smith, Kok Ping Chan, et al.. (2017). Probing the molecular determinants of fluorinase specificity. Chemical Communications. 53(17). 2559–2562. 21 indexed citations
10.
Sun, Huihua, Wan Lin Yeo, Yee Hwee Lim, et al.. (2016). Directed Evolution of a Fluorinase for Improved Fluorination Efficiency with a Non‐native Substrate. Angewandte Chemie. 128(46). 14489–14492. 14 indexed citations
11.
Sun, Huihua, Wan Lin Yeo, Yee Hwee Lim, et al.. (2016). Directed Evolution of a Fluorinase for Improved Fluorination Efficiency with a Non‐native Substrate. Angewandte Chemie International Edition. 55(46). 14277–14280. 44 indexed citations
12.
Collier, Steven J., Gjalt W. Huisman, Raquel Keledjian, et al.. (2014). Development of a Practical, Biocatalytic Reduction for the Manufacture of (S)-Licarbazepine Using an Evolved Ketoreductase. Organic Process Research & Development. 18(6). 810–815. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026